Loading insider details...
Beta
Latest Form 4 (Jun 11, 2026): Grant/Award of 637 TJX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | TJX COMPANIES INC /DE/ (TJX) | Grant/Award | 637 | n/a |
| Feb 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,744 | $846.0K |
| Feb 19, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 7,365 | n/a |
| Feb 18, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 4,565 | $2.23M |
| Feb 12, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 3,045 | $1.43M |
| Jan 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 9,440 | n/a |
| Jan 8, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Exercise/Conversion | 9,532 | $1.81M |
| Dec 5, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 7,000 | $3.16M |
| Jun 12, 2025 | TJX COMPANIES INC /DE/ (TJX) | Grant/Award | 793 | n/a |
| Mar 12, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 3,298 | $1.65M |